11 Best Hot Stocks to Buy According to Wall Street Analysts

Page 5 of 10

6. UroGen Pharma Ltd. (NASDAQ:URGN)

Gain Over the Past 1 Month: 176.02%

Number of Hedge Fund Holders: 31

Average Upside Potential as of July 3: 143.00%

UroGen Pharma Ltd. (NASDAQ:URGN) is one of the best hot stocks to buy according to Wall Street analysts. In mid-June, UroGen Pharma announced that the US FDA had approved ZUSDURI (mitomycin) for intravesical solution. This marked ZUSDURI as the first and only FDA-approved medication for adults with recurrent low-grade intermediate-risk non-muscle invasive bladder cancer (LG-IR-NMIBC).

ZUSDURI was formerly known as UGN-102 and is an innovative drug formulation of mitomycin combined with a sterile hydrogel, using UroGen’s proprietary sustained-release RTGel technology. This design allows for potent tumor ablation through non-surgical means, delivered directly into the bladder via a urinary catheter in an outpatient procedure by a trained healthcare professional.

The approval is supported by positive results from the pivotal Phase 3 ENVISION trial. The trial demonstrated that 78% of patients achieved a complete response at 3 months. Furthermore, 79% of those responders maintained their complete response at 12 months after the 3-month visit. The medication exhibited a manageable safety profile as well.

UroGen Pharma Ltd. (NASDAQ:URGN) develops and commercializes solutions for urothelial and specialty cancers.

Page 5 of 10